ASGE Annual Postgraduate Course: Clinical Challenges and Real-Time Decision Making in GI Endoscopy (Live and Virtual) | May 2023-Intragastric Balloons and the Transpyloric Shuttle

Video Transcription

Video Summary

The video is a presentation by Dr. Shelby Sullivan on different endoscopic bariatric and metabolic therapies. Dr. Sullivan introduces herself as the chair of the Association for Bariatric Endoscopy and proceeds to discuss various devices including intragastric balloons, aspiration therapy, the trans-pyloric shuttle, and the Aspire Assist system. Dr. Sullivan mentions multiple studies that have been conducted on these devices, some of which have led to FDA approval. She provides information on the different types of intragastric balloons, their indications, contraindications, and clinical considerations. She also discusses the efficacy and safety of these balloons, comparing them to other endoscopic bariatric therapies. Dr. Sullivan then moves on to discuss the Aspire Assist system, explaining how it works and addressing patient selection and clinical considerations. She concludes by discussing the trans-pyloric shuttle and the End Obesity 2 trial, which evaluated its efficacy and safety. Dr. Sullivan provides insights into weight loss outcomes, adverse events, and the commercial availability of the device. The video ends with Dr. Sullivan stating that endoscopic bariatric therapies are evidence-based treatments with potential benefits for weight loss and metabolic improvement.

Asset Subtitle

Shelby Sullivan, MD, FASGE

Keywords

endoscopic bariatric therapies

intragastric balloons

aspiration therapy

trans-pyloric shuttle

Aspire Assist system

clinical considerations

weight loss outcomes

metabolic improvement